Overview
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
"He who is faithfully analysing ... epi lepsy is doing far more than studying epilepsy" Hughlings Jackson Modifying this well-known statement by Jackson, one could say today: "He who is faithfully analysing anti-epileptic drugs is doing far more than studying anti-epileptic drugs". For these drugs not only serve to prevent epileptic fits and thus advance the treatment of epilepsy, they are also effective in the treatment of cardiac arrhythmias and trigeminal neuralgia. Furthermore, clinical pharmacologists consider anti-epi leptic drugs as model drugs in pharmacokinetics and pharmocodynamics, since reliable methods are available for their determination and their effects and side effects can be defined. The methods of estimating of drugs in body fluids provide a tool that enables us to throw light on many obscure relationships in pharmaceutical treatment. Now that we can study the pharmacokinetics and interaction of drugs in man, many hypotheses based on clinical experience alone may well be eliminated or corroborated. The grow ing body of knowledge will make us more careful about the administration of drugs in combination. Now that we can study how biological parameters interfere with drug action, we may perhaps proceed to the scientific analysis of many clinical observations that suggest the importance of such factors as age, sex, menstrual cycle, pregnancy, fever, diet, stress, sport, climate, and altitude.
Similar content being viewed by others
Table of contents (36 papers)
-
Pharmacology of Anti-Epileptic Drugs
-
Various Aspects (Varia)
-
Front Matter
-
-
Quality Control and Standardization
-
Front Matter
-
-
Methodology of Determination
-
Front Matter
-
Editors and affiliations
Accessibility information
PDF accessibility summary
This PDF is Not accessible. It is based on scanned pages and does Not support features such as screen reader compatibility or descriptions for Non-text content (e.g., images and graphs). However, it likely supports searchable and selectable text based on OCR (Optical Character Recognition). Users with accessibility needs may Not be able to use this content effectively. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility
EPUB accessibility summary
This EPUB was produced prior to the implementation of current accessibility best practices. If mathematics is present, it is represented as MathML, LaTeX, or images. Text alternatives are Not available for images, graphs, and other Non-text content. We recognise the importance of accessibility and welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility
Bibliographic information
Book title: Clinical Pharmacology of Anti-Epileptic Drugs
Book subtitle: Workshop on the Determination of Anti-Epileptic Drugs in Body Fluid II (WODADIBOF II) Held in Bethel, Bielefeld, Germany, 24 - 25 May, 1974
Editors: H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin
DOI: https://doi.org/10.1007/978-3-642-85921-2
Publisher: Springer Berlin, Heidelberg
-
eBook packages: Springer Book Archive
Copyright information: Springer-Verlag Berlin-Heidelberg 1975
Softcover ISBN: 978-3-642-85923-6Published: 04 April 2012
eBook ISBN: 978-3-642-85921-2Published: 06 December 2012
Edition number: 1
Number of pages: XII, 370
Topics: Pharmacology/Toxicology, Pharmacy, Medicine/Public Health, general